http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EC-SP055588-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c76ecadad74a1a35270b3e3a34d60f37
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-498
filingDate 2005-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e2655bd0e31f6bc6ac5de33eb36390f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b5fa74e88c9df722c7b8439af669699
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc5dde9d86b7c431fa658fbb5b82fcb6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d9b880408c85d46597d8409a7880027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f38fe647afe7a165406aa2e840ed2a00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d7ad1d4f2d581aecaffbbf4c5e71413
publicationDate 2005-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EC-SP055588-A
titleOfInvention CRYSTAL FORMS OF [4-CARBAMOIL-1- (3-FLUOROBENCIL) -2,7-DIHIDROXI-7-METHYL-OCTIL] -AMIDA OF THE QUINOXALINE-2-CARBOXYL ACID
abstract This invention relates to crystalline forms of [4-carbamoyl-1- (3-fluorobenzyl) -2,7-dihydroxy-7-methyl-octyl] -amide of quinoxaline-2-carboxylic acid, useful in the treatment or prevention of a disorder or condition through CCR1 receptor antagonization, and its methods of preparation and use.
priorityDate 2002-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433076731
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID96695
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154454810
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414045149

Total number of triples: 33.